Dr. Chinthrajah is the Interim Director of the Sean N. Parker Center for Allergy and Asthma Research and oversees the Parker Lab, Parker Clinical Translational Research Unit, and a manufacturing facility that supports many clinical translational research studies in the overlapping diseases of allergy and immunology.  Dr. Chinthrajah received her MD from Drexel University College of Medicine, completed her Internal Medicine training and a chief residency at California Pacific Medical Center, and subspecialized in Pulmonary/Critical Care and Allergy/Immunology at Boston Medical Center. Her long-term research focus is to advance the food allergy field and her team is focused on investigating novel therapeutics with broad applicability across the allergic disease spectrum beyond avoidance and reactive therapies. Her work within the field to date has elucidated safe and efficacious treatments for allergic patients, mechanistic insights into diagnostics and prognostics, and next generation therapies for the multi-allergic individual.

Dr. Sindher completed her Pediatric residency at Albert Einstein College of Medicine, Children’s Hospital at Montefiore in Bronx, NY and her fellowship in Allergy and Immunology at Children’s Hospital of Philadelphia (CHOP), Philadelphia, PA. She joined the Sean N. Parker Center for Allergy & Asthma Research (SNP center) at Stanford University in January 2017 and is now the Director of the Clinical Translational Research Unit. Dr. Sindher divides her time between clinical research trials at the Sean N. Parker Center for Allergy and Asthma Research (SNP) center and the Oral Immunotherapy Clinic at Lucille Packard Children’s Hospital (LPCH), which is focused on the care of pediatric allergy and immunology patients. Dr. Sindher is the principal investigator of several clinical trials addressing atopic conditions including food allergy, atopic dermatitis, and asthma. Her present interests lie primarily in food allergy and eosinophilic esophagitis research involving strategies for prevention, diagnostics, and novel therapeutics.

Dr. Boyd is a physician scientist who is the director of the Parker Lab and a Stanford Professor in Food Allergy and Immunology and Professor of Pathology. He received bachelor's degrees in Biochemistry at the University of Manitoba, and English Literature at Oxford University, where he was a Rhodes Scholar. He obtained his M.D. from Harvard Medical School and Ph.D. from MIT, followed by pathology residency, hematopathology fellowship, and postdoctoral research work at Stanford University. He is a recipient of the Presidential Early Career Award for Scientists and Engineers, among other honors. The Boyd laboratory uses high-throughput DNA sequencing and single-cell experiments to analyze human immune responses to infection and vaccination, as well as immunological disorders such as food allergy and immunodeficiency. Many of the laboratory’s projects analyze the responses of B cells and the genetics and functional roles of antibodies in health and disease.

After completing his PharmD degree at the University of Wisconsin – Madison, Dr. Long joined the Sean N. Parker Center for Allergy & Asthma Research in October 2014. He currently assumes the role of Director for Investigational Drug Services at the Center, additionally serving as Director for the SNP Center Food Allergen Manufacturing Facility where oral immunotherapies are produced for use in clinical trials throughout the nation. Dr. Long concurrently functions as sponsor for several Investigational New Drugs at the Center, primarily focused on the advancement and application of innovative therapeutic modalities in the treatment of food allergic patients. His current interests lie in the development and study of personalized medical interventions for individuals with food allergies, investigation into the fundamental mechanistic determinants of individual response to therapy and treatment success, and exploration of epigenetic contributions to the pathology of food allergy.